Mingazheva, E.T.,
Prokofyeva, D.S.,
Valova, Ya.V.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Valiev, R.R.,
Ekomasova, N.V.,
Faishanova, R.R.,
Romanova, A.R.,
Khusnutdinova, E.K. (2022) 2, CHEK2 and NBN genes,
potentially pathogenic genetic variants in
new breast and ovarian cancer
Gilyazova, I.R.,
Yankina, M.A.,
Kunsbaeva, G.B.,
Klimentova, E.A.,
Izmaylov, A.A.,
V.N. Pavlov,
Khusnutdinova, E.K. (2016) of prostate cancer pathogenesis and facilitate development of
new approaches for treatment of the disease.
for the development of
new approaches to the disease treatment.
KLIMENTOVA, E.A.,
GILYAZOVA, I.R.,
BERMISHEVA, M.A.,
BLINNIKOVA, A. M.,
SAFIULLIN, R.I.,
IZMAILOV, A.A.,
YANG, B.,
PAVLOV ., V.N,
KHUSNUTDINOVA, E.K. (2020) , which will make it possible both to identify
new molecular markers of the risk of developing the disease
. Simultaneously with the evolution of existing proteins, retroelements have served as sources of
new ribozymes
Khusnutdinova, E.K.,
Dzhemileva, L.U.,
Lobov, S.L.,
Kuznetzov, D.U.,
Nazirova, A.G.,
Nurgalina, E.M.,
Barashkov, N.A.,
Fedorova, S.A. (2017) .
New
approaches are developed to prevent hereditary sensorineural hearing loss
and to improve medical